
Research at ObesityWeek 2026 tracks rising obesity in Medicare, productivity losses, prior authorization denials, and GLP-1 persistence.
https://www.pharmacytimes.org/on-demand/ajmc-payer-and-specialty-pharmacy-forum-improving-the-adoption-of-oncology-biosimilars-in-practice





